Measuring The True Patient Experience In Cancer Trials With ePRO

In our recent webinar, we had the privilege of hosting PRO expert Ari Gnanasakthy from RTI Health Solutions, alongside Derk Arts, CEO & Founder of Castor. Together, they delved into the intricate landscape of measuring Patient-Reported Outcomes (PROs), drug tolerability, and quality of life in cancer trials. The discussion not only highlighted the complexities inherent in these assessments but also showcased the latest advancements shaping the field.

Now, let's distill the valuable insights shared during the webinar and examine their implications for future research. We'll explore how these insights can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.